PET With (11)C-Methyl-l-Methionine as a Predictor of Consequential Outcomes at the Time of Discontinuing Temozolomide-Adjuvant Chemotherapy in Patients With Residual IDH-Mutant Lower-Grade Glioma

The aim of this study was to clarify whether PET with (11)C-methyl-l-methionine ((11)C-met PET) can predict consequential outcomes at the time of discontinuing temozolomide (TMZ)-adjuvant chemotherapy in patients with residual isocitrate dehydrogenase gene (IDH)–mutant lower-grade glioma. PATIENTS A...

Descripción completa

Detalles Bibliográficos
Autores principales: Beppu, Takaaki, Iwaya, Takeshi, Sato, Yuichi, Nomura, Jun-ichi, Terasaki, Kazunori, Sasaki, Toshiaki, Yamada, Noriyuki, Fujiwara, Shunrou, Sugai, Tamotsu, Ogasawara, Kuniaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169872/
https://www.ncbi.nlm.nih.gov/pubmed/35452002
http://dx.doi.org/10.1097/RLU.0000000000004221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169872/
https://www.ncbi.nlm.nih.gov/pubmed/35452002
http://dx.doi.org/10.1097/RLU.0000000000004221

Ejemplares similares